Pfizer Inc. (PFE): Price and Financial Metrics

PFE POWR Grades

• PFE scores best on the Value dimension, with a Value rank ahead of 96.13% of US stocks.
• PFE's strongest trending metric is Value; it's been moving up over the last 177 days.
• PFE's current lowest rank is in the Momentum metric (where it is better than 12.41% of US stocks).

PFE Stock Summary

• PFIZER INC's market capitalization of $284,763,446,462 is ahead of 99.54% of US-listed equities.
• PFE's went public 36.95 years ago, making it older than 93.49% of listed US stocks we're tracking.
• The volatility of PFIZER INC's share price is greater than that of only 10.01% US stocks with at least 200 days of trading history.
• If you're looking for stocks that are quantitatively similar to PFIZER INC, a group of peers worth examining would be MRK, ABBV, NVO, LLY, and BABA.
• PFE's SEC filings can be seen here. And to visit PFIZER INC's official web site, go to www.pfizer.com.

PFE Valuation Summary

• In comparison to the median Healthcare stock, PFE's price/sales ratio is 45% higher, now standing at 2.9.
• Over the past 243 months, PFE's price/earnings ratio has gone down 12.7.

Below are key valuation metrics over time for PFE.

PFE Growth Metrics

Its 3 year net cashflow from operations growth rate is now at 122.51%.
• Its 3 year cash and equivalents growth rate is now at 27.52%.
• Its 4 year revenue growth rate is now at -4.1%.

Over the past 70 months, PFE's revenue has gone up $46,852,000,000.

The table below shows PFE's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	99,676	26,599	29,771
2022-06-30	101,132	31,454	29,309
2022-03-31	92,367	34,583	24,966
2021-12-31	81,288	32,580	21,979
2021-09-30	63,600	32,291	19,180
2021-06-30	51,637	23,552	13,228

PFE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PFE has a Quality Grade of B, ranking ahead of 88% of graded US stocks.
• PFE's asset turnover comes in at 0.312 -- ranking 146th of 682 Pharmaceutical Products stocks.
• XBIT, NERV, and BLUE are the stocks whose asset turnover ratios are most correlated with PFE.

The table below shows PFE's key quality metrics over time.